Kris on Oncology
Mark G. Kris, MD, is chief of the thoracic oncology service and the William and Joy Ruane Chair in Thoracic Oncology at Memorial Sloan Kettering Cancer Center in New York City, where he has been on staff since 1983. His research interests include targeted therapies for lung cancer, multimodality therapy, the development of new anticancer drugs, and symptom management with a focus on preventing emesis. In 2011, he received the ASCO Humanitarian Award.+ Add to Email Alerts
- Progression on Systemic Therapy: Additional Considerations
- How to Assess Cancer Progression Beyond Imaging Results
- Meeting Needs in the Hospital: Who Is in Charge?
- Perioperative Therapy: The New Standard in Lung Cancer Care
- How to Address Patients' Fear of Nausea During Chemotherapy
- Weighing Chemo Risks: Post-op Adjuvant and Stage IV Settings
- 'We've Not Done a Good Job': Treating and Targeted Therapy
- IASLC Issues Consensus on Neoadjuvant, Adjuvant Tx for NSCLC
- Rethinking Clinical Trial Design and Cure in NSCLC
- Call to Action: Prioritizing Cure in Lung Cancer
- 'We Need to Rethink Our Options': Lung Cancer Recurrence
- Neoadjuvant Bests Adjuvant Therapy in Lung Cancer
- Avoid Counseling Fatigue: 'Don't Give Up'
- Success in Clinical Trials: Putting Patients First
- Listen to Your Patients: Improving Antiemetic Regimens
- Toward a Cure: Chemotherapy Plus TKI in EGFR-Mutant NSCLC
- Community: Key to Keeping Up-to-Date in Thoracic Oncology
- Disappointing Sotorasib Results: How to Move Forward
- Open Medical Institute: Physicians Improving Patient Care
- Include Neoadjuvant Chemotherapy in Stage II-III Lung Cancer